Purchases and Sales Made in Q2 2024 in Protagonist Therapeutics, Inc (PTGX)
This table provides information about the institutional ownership of Protagonist Therapeutics, Inc (PTGX) during Q2 2024. The information is specifically focused on institutions that hold shares of Protagonist Therapeutics, Inc.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2024
Q2 2024
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-218K- 9.8% |
$5.36M - $7.57M
|
2M
$78.1M
|
|
|
Aug 14, 2024
Q2 2024
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-290K- 24.18% |
$7.16M - $10.1M
|
910K
$35.5M
|
|
|
Aug 09, 2024
Q2 2024
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-304K- 44.86% |
$7.5M - $10.6M
|
374K
$14.6M
|
|
|
Aug 14, 2024
Q2 2024
|
Kynam Capital Management, LP
Princeton, NJ |
SELL
|
- |
-344K- 30.08% |
$8.49M - $12M
|
800K
$31.2M
|
|
|
Aug 07, 2024
Q2 2024
|
Cowen And Company, LLC
|
SELL
|
- |
-375K- 24.1% |
$9.26M - $13.1M
|
1.18M
$46.1M
|
|
|
Aug 14, 2024
Q2 2024
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-405K- 41.43% |
$9.98M - $14.1M
|
572K
$22.3M
|
|
|
Aug 14, 2024
Q2 2024
|
Bvf Inc
San Francisco, CA |
SELL
|
- |
-437K- 11.63% |
$10.8M - $15.2M
|
3.32M
$130M
|
|
|
Aug 14, 2024
Q2 2024
|
State Street Corp
Boston, MA |
SELL
|
- |
-1.19M- 36.37% |
$29.3M - $41.4M
|
2.08M
$81.3M
|
|
|
Aug 14, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-1.53M- 81.63% |
$37.8M - $53.4M
|
345K
$13.5M
|
|
|
Oct 17, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-1.53M- 81.63% |
$37.8M - $53.4M
|
345K
$13.5M
|